Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
GeneDx Holdings Corp. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.16B | $1.14B - $1.18B | -$616.27M | $6.895 | 3 |
| Dec 2029 | $888.13M | $875.46M - $906.98M | -$472.89M | $3.97 | 5 |
| Dec 2028 | $754.33M | $743.79M - $764.87M | -$401.65M | $1.84 | 6 |
| Dec 2027 | $594.89M | $586.40M - $607.51M | -$316.75M | $1.231 | 6 |
| Dec 2026 | $478.37M | $471.55M - $488.53M | -$254.71M | -$0.071 | 6 |
| Dec 2025 | $426.85M | $420.75M - $435.90M | -$227.28M | $1.358 | 5 |
| Dec 2024 | $290.22M | $286.07M - $296.38M | -$154.53M | -$0.266 | 3 |
| Dec 2023 | $243.66M | $240.18M - $248.83M | -$129.74M | -$4.50 | 2 |
| Dec 2022 | $244.28M | $240.32M - $247.24M | -$179.68M | -$29.041 | 1 |
| Dec 2021 | $203.77M | $200.47M - $206.24M | -$149.88M | -$34.54 | 1 |